Skip to main content Skip to navigation

Warwick Ventures News 2008

19th December 2008   Precious metal could lead to next generation of cancer treatments
A precious metal which has never before been used in a clinical setting is being developed as an anti-cancer agent by Warwick researchers. The metal, osmium, is closely related to platinum, which is widely used to treat cancers in the form of the drug cisplatin. Most famously, the cyclist Lance Armstrong was treated with cisplatin for testicular cancer. .
11th December 2008   Warwick drives forward new bone implant technology for tissue engineering
A method of producing synthetic bone, using techniques normally used to make catalytic converters for cars, is being developed by researchers at WMG at the University of Warwick. The team is now working closely with Warwick Ventures, the University’s technology transfer office, to find a suitable partner to help commercialise the technology, and will be presenting their work on 9 December at the national university technology showcase event, Bioversity.
10th December 2008   New uses for old drugs
A method for discovering entirely new career paths for existing clinical drugs is being exploited by start-up company Tangent Reprofiling Ltd., following a deal just signed between the company, PepTcell Limited, the University of Warwick and Warwick spin-out company a2sp Ltd. The technique, developed at the University of Warwick, enables researchers to investigate potential new uses for drugs which are already approved for clinical use.
12th September 2008   New Fingerprint Tech Could Mean Never Losing Your Keys Again (
University of Warwick researchers have unveiled a new fingerprint recognition technology, which allows them to "unwarp" distorted prints. The technology could prove especially important in mass-market biometric access systems, which have remained elusive because of small but significant rates of false positives and negatives.
1st September 2008   Warwick Moulding Technology uses high tech in-mould watermark to protect plastic products from piracy
Researchers at Warwick Spin-out, Warwick Moulding Technology Ltd, have devised a high tech way to add Anti-counterfeiting to plastic products as they are created in the moulding process. The process could cost less than one per cent of the total cost of manufacturing the product.
27th August 2008  

Concurrent Thinking secures investment
The Mercia Technology Seed Fund, a leading provider of venture capital to early stage technology-backed businesses in the West Midlands, has just completed an investment into Concurrent Thinking, a spinout company from the University of Warwick, alongside Oxford Capital Partners and Midven.

15th August 2008   £1million boost set to help West Midlands businesses beat the credit crunch
An extra £1million is being made available by Regional Development Agency Advantage West Midlands, to help businesses fighting the credit crunch across the West Midlands. This additional funding is being made available to help a range of lenders, who operate as the Fair Finance Consortium (FFC), meet the additional demand for loans resulting from the credit crunch.
2nd August 2008   AWM Proof of Concept Fund to Launch in August '08
In May 2008 the University of Warwick Science Park along with Connect Midlands, Wolverhampton University, Staffordshire BIC and Malvern Hills Science Park became the approved bidder to manage the Advantage Proof of Concept Fund on behalf of Advantage West Midlands, (AWM). The successful consortium is now submitting a full application to Advantage West Midlands for the fund which must pass through appropriate scrutiny at the Agency before formal approval, with an anticipated launch date for the grant fund in August/September 2008.
9th January 2008   GSK Head of Pain Research Joins Warwick Spin Out as CEO
NeuroDiscovery Ltd (ASX: NDL), a neurology focused research and development company, is pleased to announce the appointment of Dr Iain Chessell as Group Chief Executive.